Ikarian Capital, LLC Icad Inc Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.11 - $17.56 $1.3 Million - $2.25 Million	-128,137 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.9 - $20.82 $1.33 Million - $1.86 Million	-89,500 Reduced 41.12%	128,137 $2.22 Million
Q1 2021 May 17, 2021	BUY	$12.57 - $21.22 $282,825 - $477,450	22,500 Added 11.53%	217,637 $4.62 Million
Q4 2020 Feb 12, 2021	BUY	$8.73 - $14.56 $120,474 - $200,928	13,800 Added 7.61%	195,137 $2.58 Million
Q3 2020 Nov 16, 2020	SELL	$8.56 - $11.6 $1.12 Million - $1.52 Million	-130,931 Reduced 41.93%	181,337 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$6.63 - $12.85 $1.36 Million - $2.64 Million	205,165 Added 191.56%	312,268 $3.12 Million
Q1 2020 May 15, 2020	BUY	$6.94 - $14.42 $743,294 - $1.54 Million	107,103 New	107,103 $786,000

5.47M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $44.8M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.